Supplements for Pregnant Women

1. Folic Acid (Folate)

• Standard dose: 400-800 mcg/day, ideally starting 1 month before conception and continuing through the first 12 weeks of pregnancy
• High-risk dose: Women with a previous pregnancy affected by a neural tube defect (NTD) should take 4 mg/day starting 1 month before conception and throughout the first trimester
• Purpose: Prevents NTDs (spina bifida, anencephaly) and reduces the risk of megaloblastic anemia
• The RDA during pregnancy is 600 mcg/day; supplementation is recommended in addition to dietary folate from food
• Rich food sources include beef liver, spinach, black-eyed peas, lentils, avocado, and fortified cereals

2. Iron

• Dose: 27 mg/day (the RDA in pregnancy, vs. 18 mg in non-pregnant women)
• Purpose: Supports the 40-50% expansion of maternal blood volume, fetal iron stores, and placental development; prevents iron-deficiency anemia - the most common nutritional deficiency in pregnancy
• Supplemental iron (typically as ferrous sulfate or ferrous gluconate) is needed because dietary intake rarely meets the increased demand
• Iron-rich foods: fortified cereals, red meat, dried beans, lentils, tofu, raisins

3. Calcium

• Dose: 1000 mg/day (women 19-39 years); 1300 mg/day (women under 18 years)
• Purpose: Fetal bone and tooth development; maternal bone preservation; may reduce risk of hypertensive disorders of pregnancy and preeclampsia (especially in women with low baseline calcium intake)
• Should be taken with adequate vitamin D and magnesium for optimal absorption
• Rich sources: dairy (milk, yogurt, cheese), fortified soy milk, sardines with bones, fortified orange juice

4. Vitamin D

• Dose: 600 IU/day (IOM recommendation); some experts and the Endocrine Society advocate 1000-4000 IU/day to achieve optimal serum 25(OH)D levels of 75-100 nmol/L
• Purpose: Calcium absorption, fetal bone development, immune function; deficiency jeopardizes maternal and fetal bone mass
• ACOG recommends considering screening women at increased risk for deficiency (dark skin, limited sun exposure, obesity, malabsorption); if deficient, 1000-2000 IU/day is considered safe
• Rich sources: cod liver oil, fatty fish (salmon, tuna), fortified milk and juice

5. Iodine

• Dose: 220 mcg/day during pregnancy (RDA); 290 mcg/day during lactation
• Purpose: Essential for fetal thyroid hormone synthesis and brain development; iodine deficiency is the leading preventable cause of intellectual disability worldwide
• Many prenatal vitamins do not contain sufficient iodine - check the label; the American Thyroid Association recommends choosing a prenatal vitamin containing 150 mcg of iodine
• Sources: iodized salt, dairy, seafood, eggs

6. DHA (Omega-3 Fatty Acid)

• Dose: 200-300 mg/day of DHA is commonly recommended
• Purpose: Fetal brain and retinal development; particularly important in the third trimester when fetal brain growth is most rapid
• Sources: fatty fish (salmon, sardines), algae-based DHA supplements (suitable for vegetarians/vegans)
• Fish oil supplements or algal DHA are typical sources when dietary intake is insufficient

7. Vitamin B12

• Dose: 2.6 mcg/day (RDA in pregnancy)
• Purpose: Neurological development, red blood cell formation, DNA synthesis; works synergistically with folate
• Especially important in vegans/vegetarians, who are at high risk of deficiency
• A 2024 Cochrane review on vitamin B12 supplementation in pregnancy (PMID 38189492) examined its role in maternal and child health outcomes

Summary Table

Latest Clinical Guidelines on Prenatal Supplementation

Major Guideline Bodies (2024-2026)

ACOG (American College of Obstetricians and Gynecologists)

WHO (World Health Organization)

• Iron: 30-60 mg elemental iron daily
• Folic acid: 400 mcg (0.4 mg) daily, beginning as early as possible in pregnancy (ideally pre-conception)
• In settings where anemia prevalence is >40%, the higher dose of 60 mg iron is recommended

NICE (UK National Institute for Health and Care Excellence)

• Folic acid 400 mcg/day preconception through 12 weeks (5 mg/day for high-risk women: diabetes, previous NTD, BMI >30, on antiepileptics)
• Vitamin D 400 IU/day throughout pregnancy and breastfeeding
• Iron - only if deficiency confirmed on testing (not routine supplementation)
• Iodine - consume iodine-rich foods; consider supplement if dietary intake is low

Key Recent Evidence (2024-2025)

1. Multiple Micronutrient Supplementation (MMS) vs. Iron-Folic Acid Alone

• MMS significantly reduced risk of preterm-SGA-LBW (RR 0.73, 95% CI 0.64-0.84), preterm-AGA-LBW (RR 0.82), and term-SGA (RR 0.93) compared to iron-folic acid alone
• MMS containing 15+ micronutrients offers substantial benefits over basic iron-folic acid in resource-limited settings

• MMS led to greater infant length, weight, and head circumference through 6 months of age vs. iron-folic acid
• Reduced risk of stunting (RR 0.86), underweight (RR 0.86), and small head circumference (RR 0.84) at 3 months

2. Iron Supplementation

• Iron supplementation probably reduces maternal iron-deficiency anemia (RR 0.41, 95% CI 0.26-0.63; moderate certainty)
• Probably reduces low birthweight (RR 0.84, 95% CI 0.72-0.99; moderate certainty)
• Little to no difference in preterm birth
• Evidence quality: moderate for key maternal outcomes; low-very low for adverse effects
• Conclusion: Daily oral iron supplementation is beneficial but should be balanced against GI side effects

3. Vitamin D Supplementation

• Evidence is now low to very low certainty after removal of studies with integrity concerns
• Vitamin D may reduce the risk of severe postpartum haemorrhage (RR 0.68; low certainty)
• May reduce low birthweight (RR 0.69; low certainty)
• Key update: The 2024 Cochrane review is more cautious than previous versions - several earlier studies were removed due to trustworthiness concerns, downgrading confidence in outcomes like preterm birth and pre-eclampsia reduction
• Clinical recommendation: supplementation remains standard at 600-2000 IU/day, but blanket claims about preventing complications are no longer well-supported by high-quality evidence

4. Folic Acid and Autism Spectrum Disorder - New Finding

• Prenatal folic acid/multivitamin supplementation associated with 30% reduced risk of ASD in offspring (RR 0.70, 95% CI 0.62-0.78; GRADE: highly suggestive)
• Multivitamin use showed 34% reduction (RR 0.66)
• This adds a new dimension to folic acid benefits beyond NTD prevention

5. Guideline Quality Assessment

• Only 6/18 CPGs (33%) were rated high quality: Spain, Australia, NICE (UK), ACOG (USA), WHO, and Denmark
• Most professional society guidelines scored lower than institutional guidelines
• Takeaway: Clinicians should preferentially follow ACOG, WHO, NICE, or equivalent institutional guidelines over professional society position statements

Summary: Current Guideline Consensus (2024-2026)